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In past years, comprehensive representations of cell
signalling pathways have been developed by manual
curation from literature, which requires huge effort and
would beneﬁt from information stored in databases and
from automatic retrieval and integration methods. Once a
reconstruction of the network of interactions is achieved,
analysisofitsstructuralfeaturesanditsdynamicbehaviour
can take place. Mathematical modelling techniques are
used to simulate the complex behaviour of cell signalling
networks, which ultimately sheds light on the mechanisms
leading to complex diseases or helps in the identiﬁcation of
drug targets. Avariety of databases containing information
on cell signalling pathways have been developed in
conjunction with methodologies to access and analyse the
data.Inprinciple,thescenario ispreparedtomakethemost
of this information for the analysis of the dynamics of
signalling pathways. However, are the knowledge reposi-
tories of signalling pathways ready to realize the systems
biology promise? In this article we aim to initiate this
discussion and to provide some insights on this issue.
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Introduction
The past decades of research have led to a better under-
standing of the processes involved in cell signalling. Cell
signallingreferstothebiochemicalprocessesusingwhichcells
respond to cues in their internal or external environment
(Alberts et al, 2007). With the advent of high throughput
experimentation, the identiﬁcation and characterization of the
molecular components involved in cell signalling became
possible in a systematic way. In addition, the discovery of the
connections between each of these components promoted the
reconstruction of the chain of reactions, which subsequently
gives rise to a signalling pathway. Ultimately, our ability to
interpret the function and regulation of cell signalling
pathways is crucial for understanding the ways in which
cellsrespondtoexternalcuesandhowtheycommunicatewith
each other.
In this regard, the systematic collection of pathway
information in the form of pathway databases and the
application of mathematical analysis for pathway modelling
are crucial. Several databases containing information on cell
signalling pathways have been developed in conjunction with
methodologies to access and analyse the data (Suderman and
Hallett, 2007). Furthermore, mathematical modelling emerged
as a solution to study the complex behaviour of networks
(Alves et al, 2006; Fisher and Henzinger, 2007; Karlebach and
Shamir, 2008). The models, so far obtained, allow formulating
hypothesis that can be tested in the laboratory. Iterative cycles
of prediction and experimental veriﬁcation have resulted in
the reﬁnement of our knowledge of cell signalling, and have
shed light on different aspects of cell signalling at a systems
level (regulatory aspects, such as feedback control circuits or
architectural features, such as modularity).
Furthermore, signalling cascades are not isolated units
within the cell, but form part of a mesh of interconnected
networks through which the signal elicited by an environ-
mental cue can traverse (Yaffe, 2008). Ultimately, each cell is
exposed to a variety of signalling cues, and the speciﬁcity of
the response will be determined by the signalling mechanisms
that are activated by the cue (Alberts et al, 2007). Recent
research highlights the importance of the, so called, crosstalks
betweenpathways,suchastherecentlypublishedconnections
between signalling through the purinergic receptors and the
Ca
2þ sensing (Chaumont et al, 2008); the link between
extracellular glycocalyx structure and nitric oxide signalling
pathway (Tarbell and Ebong, 2008); the interactions between
insulin and epidermal growth factor signalling (Borisov et al,
2009) and the crosstalk between phosphoinositide 3 kinase
and Ras/extracellular signal-regulated kinase signalling path-
ways (Wang et al, 2009).
An important goal of this research is to achieve a
reconstruction of the network of interactions that gives rise
to a signalling pathway in a biologically consistent and
meaningful manner that in turn allows the mathematical
analysis of the emerging properties of the network. In this
regard,comprehensivemapsofsignallingpathwayshavebeen
developed by manual curation from literature (Oda et al, 2005;
Oda and Kitano, 2006; Calzone et al, 2008). Building such
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information stored in databases and from automatic retrieval
andintegrationmethods.Onceareconstructionofthenetwork
ofinteractionsisachieved,analysisofthestructuralfeaturesof
the network and its dynamic behaviour can take place.
Acommonly seen architecture of signalling pathways is called
‘bow-tie’, in which many input and output signals are handled
by a common layer constituted by a small number of
conserved components. This network architecture provides
robustness and ﬂexibility to a variety of external cues due to
the redundancy of reactions that are part of the input and
output layers (Kitano, 2007a). Robustness refers to the ability
of an organism to compensate the effects of perturbations to
maintain the organism’s functions (Kitano, 2007b). Such
perturbations can be changes in the availability of nutrients
as well as the presence of mutagens or toxins. Moreover,
systems can be subjected to functional disruptions when
facing perturbations for which they are not optimized, thus
showing points of fragility of the biological system (Kitano,
2007b). For instance, an undesired effect of a drug can be
causedbytheunwantedinteractionofthedrugwithmolecules
that represent points of fragility of the physiological system
(Kitano, 2007a). In contrast, drugs can be completely
ineffective when the robustness of the system compensates
their action. It has been suggested that crosstalks between
signalling pathways contribute to the robustness of cells
against perturbations (Kitano, 2007a). In addition, the points
offragilityofthesystemaresometimesexploitedbypathogens
causing diseases,or representprocesses that areusually found
to malfunction in particular diseases, such as cancer. Diseases
that arise from dysfunction in cell signalling are usually not
attributedtoasinglegenebuttothefailureofemergingcontrol
mechanisms in the network. It has been reported that the loss
of negative feedback loops characterizes solid tumours (Amit
et al, 2007). These diseases are difﬁcult to diagnose and treat
unless accurate understanding of the underlying principles
regulatingthesystemisinplace.Thus,theinterpretationofthe
global properties of signalling pathways has important
implications for the elucidation of the mechanisms that lead
to complex diseases, and also for the identiﬁcation of drug
targets.
At present, there are several repositories of information on
cell signalling pathways that cover a wide range of signal
transduction mechanisms and include high quality data in
terms of annotation and cross references to biological
databases. In principle, the scenario is prepared to make use
of the information for the analysis of the behaviour of the
signalling pathways. Thus, are the knowledge repositories on
signalling pathways ready to realize the systems biology
promise? In this article, we aim to initiate this discussion and
to provide some insights on this issue.
First, we present an analytical overview of current pathway
databases (see Pathway databases). In section ‘Case study:
EGFR signalling’, we present the results of an evaluation
exercise conducted to determine the accuracy and complete-
nessofcurrentpathwaydatabasesinfrontofanexpert-curated
pathway used as ‘gold standard’. Moreover, we propose a
strategy for the use of pathway data from public databases for
network modelling (Box 1; Table I). Finally, in the section
‘Conclusions and perspectives’ we discuss the strengths and
limitations of the current pathway databases and their
usefulness in practical biological problems and applications.
Pathway databases
Pathway databases serve as repositories of current knowledge
oncell signalling. Theypresent pathwaysin a graphical format
comparable to the representation in text books, as well as in
standard formats allowing exchange between different soft-
ware platforms and further processing by network analysis,
visualizationand modellingtools.Atpresent, thereexistavast
variety of databases containing biochemical reactions, such as
signalling pathways or protein–protein interactions. The
Pathguide resource serves as a good overview of current
pathwaydatabases(Baderetal,2006).Morethan200pathway
repositories are listed, from which over 60 are specialized on
reactions in human. However, only half of them provide
pathways and reactions in computer-readable formats needed
for automatic retrieval and processing, and even less support
standard formats, such as Biological Pathway Exchange
(BioPAX) (http://www.biopax.org) and Systems Biology
Markup Language (SBML) (Hucka et al, 2003).
To obtain a complete view of the biological process of
interest, combination of information from diverse reactions
and pathways is often needed. A recent publication (Adriaens
et al, 2008), describes a workﬂow developed for gathering and
curating all information on a pathway to obtain a broad and
correctrepresentation.However,thedescribedprocessheavily
relies on manual intervention. Consequently, there is a need
for the automation of both the pathway retrieval process and
the integration of different data sources. This section is
devoted to the description of main pathway databases:
Reactome, Kyoto Encyclopedia of Genes and Genomes
(KEGG), WikiPathways, Nature Pathway Interaction Database
(PID) and Pathway Commons. Table II lists all pathway
databases and protein–protein interaction resources that are
mentioned in this section.
Reactome
Reactome is currently one of the most complete and best-
curated pathway databases. It covers reactions for any type of
biological process and organizes them in a hierarchal manner.
In this hierarchy, the lower level corresponds to single
reactions, whereas the upper level represents the pathway as
a whole.
Reactome was ﬁrst developed as an open source database
for pathways and interactions in human. Equivalent reactions
for other species are inferred from the human data (Vastrik
et al, 2007), providing coverage to 22 non-human species,
including mouse, rat, chicken, puffer ﬁsh, worm, ﬂy, yeast,
and Escherichia coli. Furthermore, other Reactome projects
exist focusing on single species, such as the Arabidopsis
Reactome (http://www.arabidopsisreactome.org).
All pathway and reaction data in Reactome are extracted
from biomedical experiments and literature. For this purpose,
PhD-level biologists are invited to work together with the
Reactome curators and editors on the curation of data on
selected biological processes. Once the ﬁrst outline of the
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peer reviewers and potential inconsistencies and errors are
ﬁxed. Every two years the data are reviewed to keep it updated
(Joshi-Tope et al, 2005; Matthews et al, 2009). Moreover, cross
referencestodifferentdatabases,suchasUniProt(TheUniProt
Consortium, 2008), Ensembl (http://www.ensembl.org/in-
dex.html), NCBI (http://www.ncbi.nlm.nih.gov), Gene Ontol-
ogy (GO) (Ashburner et al, 2000), Entrez Gene (Maglott et al,
2007), UCSC Genome Browser (http://genome.ucsc.edu),
HapMap (http://www.hapmap.org), PubMed, as well as to
other pathway databases, such as KEGG (Kanehisa and Goto,
2000) are provided.
Pathways are presented as chains of chemical reactions and
the same data model is used to describe reactions for any
biological process, such as transcription, catalysis or binding
(Matthews et al, 2007). Altogether, this represents a coherent
view of pathway knowledge. The data model is based on
classes, such as physical entity or event. Physical entities
comprise proteins, DNA, RNA, small molecules but also
complexes of single entities. Proteins, RNA and DNA, for
which the sequence is known, are linked to the appropriate
databases. Chemical entities such as small molecules are
linked to ChEBI (http://www.ebi.ac.uk/chebi/init.do). An
event can be either a ReactionLikeEvent, which represents
reactions that convert an input into an output, or a
PathwayLikeEvent, grouping together several related events.
Each class possesses properties, such as information on the
type of interaction (e.g. inhibition or activation). Reactome
explicitly considers the different states an entity can show in a
reaction. The phosphorylated and the unphosphorylated
version of a protein are, for example, represented as
separate entities. In addition, generalization is allowed. This
means that if two different entities have exactly the same
function in a reaction, such as isoenzymes, the reaction is
only described once and the functional equivalent entities
belong to the same deﬁned set. Another interesting
element of the Reactome data model is the use of candidate
sets, which act as placeholders for all possible entities in a
reaction, in case the exact entity involved in the reaction is not
yet known.
Reactome can either be directly browsed or queried by text
search using, for instance, UniProt accession numbers. In
addition, some tools for advanced queries are provided. The
PathFinder tool allows connecting an input to an output
molecule or event by constructing the shortest path between
both. The SkyPainter tool can be used to identify events or
pathways that are statistically over-represented for a list of
genes or proteins. Moreover, Reactome data can be combined
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Box 1 Most public, available pathway databases offer their data in BioPAX format, which was developed for detailed pathway representation and as data
exchange format. For storing and sharing of computational models of biological networks, SBML has emerged as standard and is supported by most modelling
software. BioPAX and SBML, the two main standards for the representation of biological networks, have been discussed in detail by others (Stromback and
Lambrix,2005;Strombacketal,2006).InTableI,webrieﬂylistthemostimportantfeaturesoftheSBMLandBioPAXstandards.Ascenarioinwhichpathwaydata
were directly used for network modelling is proposed here. One or more pathways represented in BioPAX format are automatically retrieved from different
databases and imported into a pathway visualization and analysis tool. Then, integration of the different pathways can take place to obtain a comprehensive and
biologicallymeaningfulrepresentation ofthenetwork.Inaddition, annotationscan beadded ifrequired orstructuralanalysisofthe networkcanbe carried out.The
resulting network, which integrates the original pathways retrieved from the databases, is exported to SBML format and subjected to modelling. If a quantitative
approachischosen,additionalinformation,suchasrateconstantsarerequired tostartthe modellingprocess.Inthisprocess,conversionbetweenthe twoformats
is required to achieve inter-operability between pathway and model representations. Some solutions are already available. The BioModels (http://www.ebi.ac.uk/
biomodels-main/) database, which contains a variety of curated models in SBML format, offers conversion to BioPAX format. The opposite conversion, from
BioPAX to SBML, would open the possibility of modelling the pathways stored in public databases. However, the inter-conversion between BioPAX and SBML is
not trivial as both formats where developed for different purposes. BioPAX, for instance, does not offer the possibility to store quantitative information needed for
kinetic modelling, whereas SBML does not represent relationships between nodes that are not needed for modelling and that are present in BioPAX. Examples of
approaches for the conversion from BioPAX to SBML are BiNoM (Zinovyev et al, 2008), which is available as Cytoscape plugin, and SyBil, which is part of the
model environment for quantitative modelling VCell (Evelo, 2009). Although compatibility of different pathway and network model exchange formats is still not
completely achieved, the efforts made towards this goal represent signiﬁcant contributions to pathway retrieval, integration and subsequent modelling.
Box 1 Use of data from public pathway databases for modelling purposes
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BioMart (http://www.biomart.org) tool.
In addition to browsing pathways through the Reactome
web interface, it is possible to download the data for local
visualization and analysis using other tools. Different formats
are provided for pathway download, including SBML Level 2,
and BioPAX Level 2 and Level 3 (for some reactions only), as
well as graphical formats. Pathway ﬁles, for instance, in
BioPAX format can be directly opened in Cytoscape (Shannon
et al, 2003), a software for the visualization and analysis of
networks. Moreover, data can be programmatically accessed
through a SOAP web service.
KEGG
KEGG is not only a database for pathways but consists of 19
highly interconnected databases, containing genomic, chemi-
cal and phenotypic information (Kanehisa and Goto, 2000;
Kanehisa et al, 2008). Here we concentrate on the database
storing biological pathways. KEGG categorizes its pathways
into metabolic processes, genetic information processing,
environmental information processing, including signalling
pathways, cellular processes, information on human diseases
and drug development. However, the best-organized and most
complete information can be found for metabolic pathways.
KEGG is not organism speciﬁc but covers a wide range of
organisms, including human. The pathways are manually
curated by experts using literature. In addition to the
interconnection of all databases underlying KEGG, links to
external databases, such as NCBI Entrez Gene, OMIM, UniProt
and GO are provided. Pathways can either be browsed or
queried by free text search. The user can search for gene
names, chemical compounds or whole pathways.Atutorial on
how to browse pathways in KEGG and an overview of the
multiple representation formats is available (Aoki-Kinoshita &
Minoru Kanehisa, 2007).
Each pathwaystoredin KEGG can be downloaded in its own
XML format named KGML, which is supported by VisANT, a
software tool for pathway visualization (Hu et al, 2008b) and
indirectly by Cytoscape using scripting plugins. In addition,
metabolic pathways are available in BioPAX Level 1,
which was especially designed for metabolic reactions, as
well as in SBML. For converting KEGG metabolic pathways to
SBML, a tool called KEGG2SBML (http://sbml.org/Software/
KEGG2SBML) was developed.
KEGG data can also be accessed using the KEGG API or
KEGG FTP. Moreover, for making use of the KEGG resources,
several applications exist. KegArray, for example, allows
the analysis of microarray data in the context of KEGG
pathways.
Table I Comparison between SBML and BioPAX
SBML BioPAX
Representation format XML (Extensible Markup Language) OWL (Web Ontology Language), XML
Main purpose Representation of computational models of biological
networks
Pathway description with all details on reactions,
components, information on cellular location etc.
Entities and reactions Based on species and reactions (Hucka et al., 2003): Basic ontology based on three classes
(http://www.biopax.org/):
Species (proteins, small molecules etc.) Pathway (set of interactions)
Reactions (how species interact) Physical entity with subclasses, such as RNA,
DNA, protein, complex and small molecules
Compartment (in which interactions take place) Interaction with subclasses, such as conversion
having biochemicalReaction as subclass, etc.
Number of pathways
represented
One model per SBML ﬁle Several pathways per BioPAX ﬁle possible (each
object has its own RDF id and is hence uniquely
identiﬁable)
Reaction kinetics Allows representation of kinetics, including parameters
for reaction rates, initial concentrations etc.
No kinetics as BioPAX is not meant for modelling but
pathway representation
Levels Built in levels with different versions. Each level adds
new features, such as the incorporation of controlled
vocabularies. At the time of writing, the most stable
version is SBML Level 2
BioPAX Level 1: representation of chemical reactions
involved in metabolism
BioPAX Level 2: adds molecular interactions and
protein post-translational modiﬁcations
BioPAX Level 3: any kind of biological reaction,
including regulation of gene expression (BioPAX L3
is at the time of writing still in release process)
The BioPAX project roadmap envisages two
additionallevelscapturinginteractionsatthecellular
level. (http://www.biopax.org/Docs/
BioPAX_Roadmap.html)
Pathway database support Reactome Reactome
KEGG KEGG (only BioPAX Level 1)
PID
PathwayCommons
Model database support BioModels BioModels (conversion from SBML to BioPAX
possible)
Library for reading/writing libSBML(Bornstein et al, 2008) Paxtools (http://www.biopax.org/paxtools/)
Software support Standard modelling software, such as CellDesigner
or Copasi (Hoops et al, 2006)
Network visualization software, such as Cytoscape
or VisANT
Network visualization software, such as Cytoscape
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A recently developed resource for pathway information that
strongly differs from other pathway repositories is WikiPath-
ways. WikiPathways is an open source project based, like
Wikipedia, on the MediaWiki software (Pico et al, 2008). It
serves as an open and collaborative platform for creation,
edition and curation of biological pathways in different
species.
WikiPathways aims to achieve a public commitment to
pathway storage and curation by keeping pathway creation
and curation processes simple. Although the curation process
of the previously described databases is subjected to experts,
any user with an account on WikiPathways can create new
pathways, and edit already existing ones.
The pathway entities are linked to reference databases,
based on the criteria provided by the editor. Hence, the
identiﬁers depend on the chosen reference database and can
therefore differ between pathways and even within a single
pathway.
Pathways in WikiPathways can be browsed by species and
categories, for example, Metabolic Process. They can also be
searched using gene, protein or pathway name or any free text
query. In addition, pathways can be programmatically
accessed through a web service (http://www.wikipathways.
org/index.php/Help:WikiPathways_Webservice).
For pathway data exchange, WikiPathways does not use
standard formats like BioPAX or SBML, but offers a much
simpler representation called GenMAPP Pathway Markup
Language (GPML) that is compatible with visualization and
analysis tools, such as Cytoscape, GenMAPP (Salomonis et al,
2007)andPathVisio(vanIerseletal,2008).TheuseofGPMLis
in agreement with the community annotation nature of the
project, as it offers a simple pathway representation and
several functionalities for building network diagrams. How-
ever, inter-operability with other pathway databases is
impeded,andsubstantialeffortstowardscombiningWikiPath-
ways with the other pathway repositories will be required. In
this regard, some approaches with the objective of conversion
between GPML and standard pathway exchange formats,
such as SBML and BioPAX, are under development (Evelo,
2009). In addition, KEGG pathways in KGML format are also
available in GPML format ready for download (http://
www.pathvisio.org/Download#Step_3) or can be converted
into GPML (http://www.bigcat.unimaas.nl/tracprojects/
pathvisio/wiki/KeggConverter).
The exponential growth of biological data poses a challenge
to the high-quality annotation and curation of databases. In
this scenario, the use of wikis for community curation of
biological data have emerged in the past years with the goal of
increasingqualityof data annotation bycombining knowledge
from multiple experts (Giles, 2007; Waldrop, 2008; Hu et al,
2008a). However, their success will strongly depend on the
commitment of the community and WikiPathways authors
claimthat theinitiative representsanexperiment,inwhich the
‘community curation’ approach is being tested (Pico et al,
2008). Thus, WikiPathways can be seen as a complementary
Table II Online pathway and protein–protein interaction (PPI) databases
Pathway/PPI database Web link Standard exchange formats for
download
Web service API
Reactome http://www.reactome.org BioPAX Level 2 SOAP web service API
BioPAX Level 3 (only some
reactions)
Detailed user manual available, example
client in Java
SBML Level 2
KEGG http://www.genome.jp/kegg/
pathway.html
KGML (default format) SOAP web service API
BioPAX Level 1 (only metabolic
reactions)
Example client in Java, Ruby, Perl
SBML (using converter) Direct import into Cytoscape
GPML (using converter)
WikiPathways http://www.wikipathways.org GPML (default format) SOAP web service API
Converters to standards, such
as SBML and BioPAX are
in progress
Example clients in Java, Perl, Python, R
NCI/Nature Pathway
Interaction Database
(PID)
http://pid.nci.nih.gov PID XML (default format) Access through Pathway Commons
BioPAX Level 2
BioCarta http://www.biocarta.com BioPAX Level 2 through NCI/
Nature Pathway Interaction
Database (PID)
Pathway commons http://www.pathwaycommons.org BioPAX Level 2 (default format
for pathways)
HTTP URL-based XML web service
through cPath
PSI-MI (default format for
protein–protein interactions)
Direct import into Cytoscape
Cancer cell map http://cancer.cellmap.org BioPAX Level 2 HTTP URL-based XML web service via cPath
HumanCyc http://humancyc.org BioPAX Level 2 Access through Pathway Commons and
Pathway Tools (Karp et al, 2002)
BioPAX Level 3
IntAct www.ebi.ac.uk/intact/ PSI-MI Access through Pathway Commons
HPRD http://www.hprd.org PSI-MI Access through Pathway Commons
MINT http://mint.bio.uniroma2.it/mint/ PSI-MI Access through Pathway Commons
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databases, like Reactome or KEGG.
In contrast to the aforementioned databases, the systems
described below combine diverse pathway repositories, and
can be seen as ﬁrst attempts towards the integration of
pathway information from various sources.
Nature pathway interaction database
PID contains data on cell signalling in humans (Schaefer et al,
2009). PID combines three different sources: the NCI-curated
pathways that are obtained from peer reviewed literature, as
well as pathways imported from Reactome and BioCarta.
Similar to Reactome, PID structures pathways hierarchically
into pathways and their sub-pathways that are called sub-
networks in PID.
The PID data model is based on molecular interactions in
which input biomolecules are transformed into output
biomolecules. Each process can be promoted or inhibited by
regulators. Biomolecules are proteins, RNA, complexes or
small molecules. DNA is not a part of the PID data model and
only output RNA and regulator are represented in transcrip-
tional processes. Each protein is cross-referenced to UniProt,
RNA to Entrez Gene, small molecules to the Chemical
Abstracts Service (CAS) registry number and complexes are
annotated using GO terms. Different states of biomolecules,
such as ‘active/inactive’ or ‘phosphorylated’ are part of the
annotations of the biomolecule. Cellular location, biological
processes and molecular function of the entities are cross-
linked to GO. Moreover, interactions are annotated with the
supporting literature or other evidence, such as inferred from
array experiment (Schaefer et al, 2009).
Pathways can be browsed and queried using gene or protein
identiﬁers, such as Entrez Gene identiﬁer, UniProt accession
numbers or HUGO gene symbols, as well as biological process
terms from GO, among others. The system returns available
results from each of the three sources. Moreover, PID offers
advanced queries. The connected molecules search option
allowsﬁndingapossiblepathbetweentwoormoremolecules.
In the batch query, the user can upload lists of gene or protein
identiﬁers and obtain a list of pathways ranked by the
probability of including the entities of the query list. Using
this application, pathways over-represented in a set of genes,
forexample, derived from microarrayexpression experiments,
can be obtained.
PID provides different pathway representation formats,
including BioPAX Level 2 and a PID proprietary XML format.
Data from Reactome are directly imported using the BioPAX
Level 2 format and is regularly updated. As not all entities or
events stored in Reactome can be presented in BioPAX Level 2,
some information is lost during the import. However, this
might be avoided once BioPAX Level 3 is released. The
BioCarta data are manually assigned to the PID data model, as
BioCarta only offers a graphical cartoon view of the pathways
and does not provide computer readable download format.
Pathway commons
Pathway Commons is a compilation of the public pathway
databases Reactome, PID and Cancer Cell Map as well as
protein–protein interaction databases, such as HPRD (Mishra
et al, 2006), HumanCyc, IntAct (Kerrien et al, 2007a) and
MINT(Zanzonietal,2002).Herein,thepathwayhierarchiesof
Reactome and PID are conserved.
Pathway Commons serves as an access point for a collection
of public databases and provides technology for integrating
pathway information. Pathway creation, extension and cura-
tion remain the duty of the source pathway databases. As a
consequence, entries in Pathway Commons are cross-linked to
their source database, and links to external databases rely on
the source database.
A regular search is provided and a ﬁlter can be set for
restricting the results to source and organism. Furthermore,
Pathway Commons provides a web service API for an
automatic access of the data. In addition, cPath, a Java open-
sourcesoftwareforaggregating,storingandqueryingpathway
data,isoffered.Oneofitskeyfeaturesistheidentiﬁermapping
system. It handles mapping tables of equivalent entities, such
as the UniProt and the RefSeq accession number of proteins.
These tables can in principle be used to integrate data from
diverse sources that use different identiﬁers. Moreover, the
system can straightforwardly be extended including self-
created mapping tables. PSI-MI (Kerrien et al, 2007b) and
currently BioPAX Level 2 exchange format are supported.
Furthermore, the complete Pathway Commons database can
beautomaticallyaccessedusingthePathway Commonsplugin
in Cytoscape.
The systems presented above allow the access to a wide
range of data on biological pathways. However, there is
overlap in the information offered by different databases. In
contrast, for speciﬁc pathways some databases offer more
accurate and complete information than others. Hence, the
user might have difﬁculties in choosing the right database and
in dealing with redundancies and inconsistencies among the
pathways. The integration initiatives exempliﬁed by PID and
Pathway Commons are attempts to solve these problems.
However, the intended integration is not trivial as the data are
fragmented and stored in databases that may differ in the
representation of the biochemical reactions, as well as in the
coverage and accuracy of annotations. In addition, often data
are not provided in interchangeable formats hampering the
automatic integration.
Case study: EGFR signalling
The epidermal growth factor receptor (EGFR) signalling
cascade is one of the best-studied and most important
signalling pathways in mammals. It regulates cell growth,
survival, proliferation and differentiation. Recently, a detailed
and comprehensive map of the EGFR signalling pathway has
beenreported(Odaetal,2005).Asthemapwasbuiltmanually
by experts using the literature, it can be seen as a reference
representation of the pathway. Other reference maps of
important signalling pathways have been reported previously
(Oda and Kitano, 2006; Calzone et al, 2008; Herrgard et al,
2008), providing the scientiﬁc community with comprehen-
sive maps that can be used for modelling, which in turn will
shed light on important aspects of cell signalling. However,
these initiatives constitute huge efforts and, as judged by the
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between the amount of data available in public databases and
the availability of such references map. Hence, we argue that
public pathway databases could be used to build such
reference maps of signalling pathways. Most pathway data-
bases are also developed by experts in the ﬁeld and constitute
repositories of high-quality data, with the additional advan-
tage of being already represented in machine readable formats
that could, in principle, be easily and automatically retrieved,
analysed and fed into modelling software tools.
We selected the EGFR pathway (Oda et al, 2005), hereafter
referred to as EGFR map, as a ‘gold standard’ to evaluate the
completeness and accuracyof publicpathwaydatabases in the
representation of the reactions that are part of the EGFR
signalling (Figure 1). We based our selection on the following
reasons:(i)signallingthroughEGFRhasbeenstudiedformore
than 40 years and a lot of information about the reactions is
already available (Citri and Yarden, 2006); (ii) it has been
carefully curated by experts; (iii) it constitutes an excellent
example of crosstalk between different signalling events, thus
allowing evaluation of the coverage of crosstalks in the public
databases and the ability of network analysis tools to retrieve
and combine networks in a meaningful manner; (iv) the study
of signalling through EGFR has important implications for
understanding several cancer types and the development of
new therapeutic strategies. Several computational models
have been reported on different aspects of EGFR signalling
(Kholodenko et al, 1999; Schoeberl et al, 2002; Hornberg et al,
2005; Birtwistle et al, 2007; Borisov et al, 2009; Li et al, 2009).
However, it is worth mentioning that, to the best of our
knowledge, no model for the whole EGFR map has been
reported till now.
In the following paragraphs and in Figures 1–3, we use the
same notation of entities as in the SBML ﬁle of the EGFR map
(Oda et al, 2005). The EGFR map is based on more than 240
publicationsandcontainsseveralcrosstalksbetweentheEGFR
downstream signalling and other signalling pathways. In the
EGFR map, depicted in Figure 1, entities are clustered
according to their cellular location and function. The
functional units comprise receptor endocytosis, recycling
and degradation, small GTPase signalling, MAPK cascade,
PIP signalling, cell cycle, Ca
2þ signalling and GPCR-mediated
transactivation. Seven phenotypic outcomes of EGFR signal-
ling are depicted: ErbB endocytosis, ErbB degradation,
apoptosis, actin reorganization, cell cycle, gene transcription
and mitogenesis/tumourigenesis.
To address the completeness and accuracy of pathway
information available in public databases and its automatic
retrieval, we tried to recover the complete EGFR map. For this
purposewequeried Reactomeversion 26 with the term ‘EGFR’
and its UniProt identiﬁer ‘P00533’ and downloaded and
visualized the retrieved pathways. Reactome was chosen as
it is currently the most detailed pathway repository, and
utilizes a data model that accommodates different types of
biochemical reactions. For visualization, we chose Cytoscape
because of its user-friendly visualization capabilities and its
network analysis tools. To map the entities found in Reactome
to those in the EGFR map, a mapping through standard
identiﬁers was carried out. We compared the original EGFR
map with the EGFR pathway recovered from Reactome (in
BioPAX format) and coloured entities and reactions according
to their representation in both resources (see Figure 1). Red
entities are found to be identical in the EGFR pathway in
Reactome and the EGFR map. Purple connotes entities that
could be recovered from Reactome but that are differently
represented (for instance, if a single protein instead of a
complex is described to take part in a reaction).
Onlya small proportion of the originalEGFR reactions could
be recovered from Reactome, and most of them are directly
related to signals coming from downstream EGFR signalling.
Most of the reactions related to other signalling cascades are
not connected with EGFR signalling in Reactome and could
therefore not be recovered. Regarding the associated pheno-
types, only two were found in Reactome: EGFR endocytosis
and EGFR degradation. However, both mechanisms are
described in a slightly different manner, in some cases even
with more details than in the original EGFR map. In a second
step, we tried to extend the EGFR map by querying Reactome
with keyentities found in the EGFR map to complete signalling
cascades, such as the GPCR signalling or the MAPK cascade
that are missing in the EGFR pathway in Reactome. All
pathways that were added are listed in Table III. We used
additional colours to depict the entities that were recovered in
this extension process. Green was used for entities found in
Reactome and the EGFR map, and turquoise was used for
entities that differed in their representation in both sources
(thecolouredEGFRmapisavailableinXMLandpdfformatsas
Supplementary information). By this extension, we were able
to recover four of the ﬁve missing phenotypes: actin
reorganization, apoptosis, cell cycle and the transcription of
target genes.However, some reactions were still missing in the
information recovered from Reactome and in some cases gaps
or contradictions appear impeding an automatic integration
(Figure 2). In this example, reactions in which ERK1 and ERK2
participate are ﬁrst separately described and later the
representation switches towards a combined ERK1/2 entity.
Regarding the reactions that give rise to regulatory loops in
the EGFR map, only some of them could be recovered from
Reactome. For instance, although the reaction that involves
cleavage of pro-HB-EGF by ADAMs is described, its regulation
by Pyk2 and c-Src is not included and therefore this positive
feedback loop is not coloured in the EGFR map. In total, three
of the six negative feedback loops were detected: inhibition of
EGFR by SHP1, downregulation of EGFR and phosphorylation
of SOS1 by ERK1, which leads to SOS1 inhibition.
Althoughmostofthecrosstalksbetweensignallingcascades
in the EGFR signalling could be established by the extension
process, a signiﬁcant number were not found because the
entities that link the different cascades are missing in
Reactome. For example, the important crosstalk of the Ca
2þ
and the EGFR signalling by the effect of Ca
2þ on Pyk2 activity
could not be recovered, as Pyk2 is not present in Reactome.
Moreover,itisworthmentioningthatdetailsaboutsomeofthe
reactions differ between the EGFR map and the data found in
Reactome. In part, this can be explained by the fact the former
is based on literature curated in 2005, and version 26 of
Reactome was released in October, 2008.
The extension process was achieved by searching the
database with entities representing the main signalling
cascades that are known to be connected with the EGFR
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that connect the pathways. In principle, the process of ﬁnding
the connections or crosstalks between pathways could be
automated using tools available in Cytoscape or Pathway
Commons (cPath). The Cytoscape merging function was
evaluated for this purpose. This function compares the
EGFR map Reactome
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Translocation to
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ERK1, ERK2 and 
ERK1/2
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MKK1, MKK2 from
ERK1, ERK2
XX
X X
Figure 2 Comparison of ERK signalling as found in the EGFR map and in Reactome. In Reactome, ERK1 or ERK2 are phosphorylated by MKK1 or MKK2,
respectively. The same reaction is found in the EGFR map, but here ERK1 and ERK2 are represented as a single entity, namely ERK1/2, which combines both
proteinsandcan be phosphorylatedby MKK1andMKK2.InReactome, dimerization andtranslocationtothe nucleus are stillseparately described for eachentity. Then,
therepresentationswitchesfromseparateentitiestoonecombinedentity.Inaddition,thedissociationofMKK1orMKK2,whichisneededbeforethedimerizationofERK
can take place, is not described in Reactome. Manual intervention is needed to correctly map both representations.
Figure1 EGFR map.EGFR mapcreated using CellDesigner ver.2.0 (Oda et al,2005). Thismap hasbeen coloured toshow theentities andreactions thatare in
commonbetweenthe EGFR mapandinformation found inReactome.Red colour denotesthattheentities andreactions areequivalent,purpleconnotes thatthey are
similar but differ in some description details, and white is used for entities and reactions that could not be directly found in Reactome. In a second step, the map was
extended byquerying Reactome with keyentities appearing inthe EGFR map,which were missing inthe representation of the EGFR pathway inReactome. After this
extension process, we coloured new equivalent entities in green and new similar entities (the ones that are differently described in both resources) in turquoise. For
comparingthe EGFRmap withthe pathwaysdownloaded fromReactome, the Reactomepathways havebeen importedintoCytoscape andtheentities andreactions
havebeenmanuallycomparedusingthe nodeandedgesearchfunctionsofCytoscape.As theSBMLversionofthe EGFRmap doesnot containuniqueidentiﬁers for
the nodes (species), all names have been ﬁrst matched to Entrez Gene identiﬁers, which have then been used for comparing entities between the EGFR map and
Reactome. In the extension process canonical names as well as Entrez Gene and UniProt identiﬁers have been used to retrieve all the information available in
Reactome. In some cases, when no results were obtained in this way, the search was additionally expanded. For example, to ﬁnd the EGFR crosstalk with the GPCR
signalling, we additionally searched for ‘G protein’. GPCR signalling pathways activated by S1P1, S1P2/3, LPA1, LPA2,E P 3 and EP2/4 were not found in Reactome.
Instead, GPCR signalling through thrombin and glucagon receptors that are related to EGFR signalling (Prenzel et al, 1999; Buteau et al, 2003) are present in
Reactome and were incorporated into the EGFR map to complete the missing crosstalk.
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different pathways. However, when tested on the reactions in
the EGFR map, several problems arose. Most of them appeared
as a result of annotation issues. For instance, Figure 3 shows
two reactions in which the two IP3 entities are differently
annotated. The ﬁrst IP3 entity is located in the ‘cytosol’,
whereas this cellular location annotation is missing for the
second IP3, precluding the expected merging of the two
reactions. Hence, an automatic integration is impeded and
manual intervention is needed. Another factor that hampers
ﬁnding connections between reactions or pathways is the use
of combined entities. For instance, the already mentioned
ERK1 and ERK2 proteins ﬁrst represented as separate entities
arelaterdescribedasacombinedERK1/ERK2entity(Figure2).
This problem could be solved by considering all the annota-
tions of the nodes while deciding whether two entities are
equivalent or not. This would allow comparing nodes that
represent states of entities, for instance, post-translational
modiﬁed proteins or proteins annotated using cellular loca-
tions. In summary, reconstruction of crosstalks between
signalling pathways is difﬁcult by means of the automatic
tools currently available. Manual intervention is required to
recover all reactions involved in the pathways and their
crosstalks.
The case study presented here shows that a process
combining automatic retrieval and manual intervention can
be used to reconstruct the EGFR map in its main features.
This shows that current pathway databases contain a lot of
detailed information though in some cases this information
is still incomplete and manual intervention is needed to
obtain a complete and correct network representation contain-
ing different signalling pathways. This is especially critical
for reactions that are part of regulatory feedback loops, as
these determine the dynamic behaviour of the signalling
pathway. Nevertheless, information obtained for individual
reactions and even for some pathways is quite complete and
would be accurate enough as a starting point for model
building. A proposal for a strategy for the use of pathway
data from public databases for network modelling is presented
in Box 1.
 Active PLC
hydrolyses PI4,5-P2
IP3 binds with the IP3
receptor, opening
the Ca2+ channel
X
Y
Cytosol Plasma membrane
Figure 3 Example—annotation issue. The two reactions ‘Active PLCg hydrolyses PI4,5-P2’ (REACT_12078.2) and ‘IP3 binds with the IP3 receptor, opening the
Ca2þ channel’(REACT_12008.1)areconnectedthroughtheentityIP3asthehydrolysisofPI4,5-P2resultsinDAGandIP3,andthenIP3bindstoitsreceptorenabling
the Ca
2þ release. However, the process in which IP3, located in the cytosol, translocates to the plasma membrane to bind to its receptor is not precisely described in
Reactome, leading to differences in the annotation of both IP3 entities. This precludes the automated merging of both chains of reactions and manual intervention was
needed to connect the reactions correctly.
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In this paper, wehave reviewed the main knowledgeresources
of human pathways, and we have evaluated the feasibility of
using this information for the reconstruction of signalling
pathways in a biologically meaningful manner. Moreover, we
have presented a scenario in which data from public pathway
databases are directly used for modelling (see Box 1). In this
regard, we have brieﬂy discussed the main standards for
representation of biological networks, BioPAX and SBML.
Furthermore, we have discussed the advantages and draw-
backs of current methods for pathway retrieval and integra-
tion, using the EGFR signalling as an illustrative example.
We encourage the combination of data from different
pathway databases, as they are often complementary and, in
this way, a better coverage of all the reactions involved in a
given pathway will be achieved. However, the integration of
pathways from different databases poses a challenge, as
different standard formats are used and data models vary.
Even if we choose a single database as a source of pathway
information,theretrievalofasignallingpathwayinconjunction
with its crosstalks to other signalling cascades is a difﬁcult task.
Althoughinthiscasethedatamodelandrepresentationformats
are not an issue, there are still annotation problems that remain
to be solved to allow an effective integration of reactions and
pathways. In this regard, the communication of these problems
todatabasecuratorsbytheuserswillbeofgreathelptoimprove
the completeness and quality of annotations.
There is a strong need of tools for the automatic integration
of different pathways in a biological meaningful way. The
analysispresentedherestressesthatthisisnotatrivialtask.As
several annotation problems and inconsistencies exist, man-
ual intervention is needed to achieve the integration. More-
over,otherfactorshavetobeconsideredtodecidewhethertwo
pathways can be merged: are the pathways found in the same
cell type? Or, are they found at the same developmental stage
of the cell? Accurateannotation of the reactions taking place in
eachsignallingpathwaywillberequiredtoappropriatelysolve
these questions.
The case study on the EGFR signalling has highlighted
very important issues for the practical use of pathway
databases. The information obtained for individual reactions
and even for particular pathways is quite complete in most
of the cases and would be accurate enough as a starting point
for modelling. Although we did not carry out a systematic
evaluation of all the reactions found in Reactome, on the
basis of the results of this case study we can conclude that
public databases contain accurate and quite complete
information about the main processes involved in cell
signalling pathways. However, for processes for which no
such level of detail on the reactions is available, the
representation recovered from public databases will be less
complete. For example, comparison of manually created
Rb/E2F pathway with data from Reactome indicated that the
latter does not coverall the reactions (Calzone et al, 2008). We
foresee that in the following years, the coverage of the
databases will grow as well as the quality of the annotations,
which will beneﬁt the scientiﬁc community in providing a
source of representations of pathways for modelling purposes.
We would like to ﬁnish by stressing the importance of the
annotation and data representation issues for an effective
integration of data from public pathway databases. Researchers
involved in pathway annotation and in pathway modelling
should engage in collaborative projects to take advantage of the
data alreadyavailableinpublicdatabases andwork togetheron
representations that ﬁt the needs of both communities.
Supplementary information
Supplementary information is available at the Molecular
Systems Biology website (www.nature.com/msb).
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Table III Pathways downloaded for extending the EGFR map
Extension to Reactome pathways downloaded Reactome
identiﬁer
MAP kinase RAF activation REACT_2077.4
cascade MAP kinase cascade REACT_634.4
ERK1/2 activates ELK1 REACT_12406.1
ERK1/2/5 activate RSK1/2/3 REACT_12487.1
RSK1/2/3 phosphorylates CREB
at serine 133
REACT_12622.1
Ca
2+ signalling Active PLCG1 hydrolyses PIP2 REACT_12078.2
DAG stimulates protein kinase
C-delta
REACT_12062.1
IP3 binds to the IP3 receptor,
opening the Ca
2+ channel
REACT_12008.1
Release of calcium from
intracellular stores by IP3
receptor activation
REACT_12074.1
Calcium binds calmodulin REACT_12602.1
GPCR signaling Thrombin-activated activation
cascade
REACT_57.1
Glucagon signalling in
metabolic regulation
REACT_1665.2
Cell cycle p53-dependent G1/S DNA
damage checkpoint
REACT_85.1
NRAGE signals death through
JNK
REACT_13638.1
Activation of BAD and
translocation to mitochondria
REACT_549.2
BH3-only proteins associate
with and inactivate
anti-apoptotic BCL-2 members
REACT_330.1
Cyclin D-associated events
in G1
REACT_821.2
Cyclin E-associated events
during G1/S transition
REACT_1574.2
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